{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:42Z","timestamp":1792784982071,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Guru Jambheshwar University of Science & Technology, Hisar, Haryana","id":[{"id":"https:\/\/ror.org\/02zpxgh81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.biopha.2017.12.016","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T09:17:51Z","timestamp":1514366271000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Potential effect of spermidine on GABA, dopamine, acetylcholinesterase, oxidative stress and proinflammatory cytokines to diminish ketamine-induced psychotic symptoms in rats"],"prefix":"10.1016","volume":"98","author":[{"given":"Monu","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Parle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.12.016_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2013.00031","article-title":"NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia","volume":"7","author":"Snyder","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2017.12.016_bib0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","article-title":"Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia","volume":"73","author":"Fineberg","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2017.12.016_bib0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10787-017-0340-5","article-title":"Potential drug targets and treatment of schizophrenia","volume":"25","author":"Kumar","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2017.12.016_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-003-1683-8","article-title":"Serotonin receptors represent highly favourable molecular targets for cognitive enhancement in schizophrenia and other disorders","volume":"174","author":"Roth","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2017.12.016_bib0025","first-page":"24","article-title":"A review on psychosis and anti-psychotic plants","volume":"8","author":"Yadav","year":"2015","journal-title":"Asian. J. Pharm. Clin. Res."},{"key":"10.1016\/j.biopha.2017.12.016_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-244X-13-37","article-title":"Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study","volume":"13","author":"Cahoon","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopha.2017.12.016_bib0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1582-4934.2004.tb00478.x","article-title":"Effects of estrogen and progesterone treatment on rat hippocampal NMDA receptors: relationship to Morris water maze performance","volume":"8","author":"El-Bakri","year":"2004","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2017.12.016_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2007.05.005","article-title":"Alterations of hippocampal and prefrontal gabaergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism","volume":"97","author":"Braun","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.biopha.2017.12.016_bib0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2045125311400779","article-title":"Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?","volume":"1","author":"Stone","year":"2011","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.biopha.2017.12.016_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2013.00052","article-title":"NMDA receptor activity in neuropsychiatric disorders","volume":"4","author":"Lakhan","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2017.12.016_bib0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2014.02.035","article-title":"Spermidine improves fear memory persistence","volume":"730","author":"Signor","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.12.016_bib0060","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.4161\/15384101.2014.973309","article-title":"Spermidine protects against \u03b1-synuclein neurotoxicity","volume":"24","author":"Buttner","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2017.12.016_bib0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000356748","article-title":"Molecular basis of the \u2018anti-aging' effect of spermidine and other natural polyamines-a mini-review","volume":"60","author":"Minois","year":"2014","journal-title":"Gerontology"},{"key":"10.1016\/j.biopha.2017.12.016_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12974-014-0220-5","article-title":"Spermine reverses lipopolysaccharide-induced memory deficit in mice","volume":"12","author":"Fruhauf","year":"2015","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.biopha.2017.12.016_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-016-2718-x","article-title":"Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats","volume":"417","author":"Singh","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2017.12.016_bib0080","first-page":"1","article-title":"Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations","author":"Yadav","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2017.12.016_bib0085","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuropharm.2012.05.041","article-title":"Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice","volume":"63","author":"Chatterjee","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.12.016_bib0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.7324\/JAPS.2016.60527","article-title":"Evaluation of antipsychotic effect of methanolic extract of Ocimum sanctum leaves on laboratory animals","volume":"6","author":"Sharma","year":"2016","journal-title":"J. App. Pharm. Sci."},{"key":"10.1016\/j.biopha.2017.12.016_bib0095","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/10717544.2017.1377315","article-title":"Brain targeted oral delivery of doxycycline hydrochloride encapsulated tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice","volume":"24","author":"Yadav","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2017.12.016_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainresbull.2010.05.011","article-title":"Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice","volume":"83","author":"da Silva","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2017.12.016_bib0105","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2017.12.016_bib0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1472-8206.2012.01040.x","article-title":"Anti-depressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress","volume":"27","author":"Chillar","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2017.12.016_bib0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulphydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2017.12.016_bib0120","first-page":"475","article-title":"The effect of inorganic iron on the thiobarbituric acid method for the determination of lipid peroxides","volume":"84","author":"Wills","year":"1964","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.biopha.2017.12.016_bib0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2017.12.016_bib0130","first-page":"8","article-title":"The fluorimetric measurement of glutamic, decarboxylase measurement and its distribution in brain","volume":"3","author":"Lowe","year":"1958","journal-title":"J. Neuro Chem."},{"key":"10.1016\/j.biopha.2017.12.016_bib0135","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/0006-2952(74)90235-4","article-title":"A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue","volume":"23","author":"Schlumpf","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2017.12.016_bib0140","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/00048670903001943","article-title":"Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin\/ErbB4 and synapse regression","volume":"43","author":"Bennett","year":"2009","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.biopha.2017.12.016_bib0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuint.2005.11.019","article-title":"Repeated injection of MK801: an animal model of schizophrenia?","volume":"48","author":"Eyjolfsson","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2017.12.016_bib0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psychres.2009.11.008","article-title":"Glycine serum level in schizophrenia: relation to negative symptoms","volume":"176","author":"Hons","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.biopha.2017.12.016_bib0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbr.2010.08.001","article-title":"Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis","volume":"216","author":"Chatterjee","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.12.016_bib0160","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/j.bmcl.2013.07.019","article-title":"Modulation of NMDA receptor function as a treatment for schizophrenia","volume":"23","author":"Cioffi","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2017.12.016_bib0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.biopha.2017.12.016_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fpsyt.2014.00011","article-title":"A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation","volume":"5","author":"Kroken","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2017.12.016_bib0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuroscience.2013.11.049","article-title":"Omega-3 prevents behaviour response and brain oxidative damage in the ketamine model of schizophrenia","volume":"259","author":"Zugno","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2017.12.016_bib0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1423-0127-19-31","article-title":"Anti-inflammatory effects of spermidine in lipopolysaccharide-stimulated BV2 microglial cells","volume":"19","author":"Choi","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2017.12.016_bib0185","first-page":"517","article-title":"Exogenous spermidine improves water stress tolerance of white clover ('Trifolium repens' L.) involved in antioxidant defence, gene expression and proline metabolism","volume":"7","author":"Li","year":"2014","journal-title":"Plant Omics"},{"key":"10.1016\/j.biopha.2017.12.016_bib0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4161\/auto.26918","article-title":"Spermidine-triggered autophagy ameliorates memory during aging","volume":"10","author":"Sigrist","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2017.12.016_bib0195","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s11064-017-2177-0","article-title":"Trachyspermum ammi seeds supplementation helps reverse scopolamine, alprazolam and electroshock induced amnesia","volume":"42","author":"Soni","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2017.12.016_bib0200","first-page":"2","article-title":"Acetylcholinesterase inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report","volume":"10","author":"Patel","year":"2010","journal-title":"BMC Psychiatry"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217346966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217346966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:25:37Z","timestamp":1760095537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217346966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"alternative-id":["S0753332217346966"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.016","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential effect of spermidine on GABA, dopamine, acetylcholinesterase, oxidative stress and proinflammatory cytokines to diminish ketamine-induced psychotic symptoms in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}